BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 28593583)

  • 1. Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy.
    Kitada M; Ogura Y; Monno I; Koya D
    Curr Diab Rep; 2017 Jul; 17(7):53. PubMed ID: 28593583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy.
    Kume S; Koya D; Uzu T; Maegawa H
    Biomed Res Int; 2014; 2014():315494. PubMed ID: 25126552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
    Packer M
    J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy: emerging therapeutic target for diabetic nephropathy.
    Kume S; Yamahara K; Yasuda M; Maegawa H; Koya D
    Semin Nephrol; 2014 Jan; 34(1):9-16. PubMed ID: 24485025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of autophagy in the pathogenesis of diabetic nephropathy.
    Yamahara K; Yasuda M; Kume S; Koya D; Maegawa H; Uzu T
    J Diabetes Res; 2013; 2013():193757. PubMed ID: 24455746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy.
    Kume S; Koya D
    Diabetes Metab J; 2015 Dec; 39(6):451-60. PubMed ID: 26706914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.
    Koya D; Kitada M; Kume S; Kanasaki K
    Clin Exp Nephrol; 2014 Apr; 18(2):210-3. PubMed ID: 24221306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy.
    Zhang M; Zhang Y; Xiao D; Zhang J; Wang X; Guan F; Zhang M; Chen L
    Eur J Pharmacol; 2020 Apr; 873():172955. PubMed ID: 32001218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in Immune-Related Renal Disease.
    Ye X; Zhou XJ; Zhang H
    J Immunol Res; 2019; 2019():5071687. PubMed ID: 31815154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity.
    Kitada M; Ogura Y; Suzuki T; Sen S; Lee SM; Kanasaki K; Kume S; Koya D
    Diabetologia; 2016 Jun; 59(6):1307-17. PubMed ID: 27020449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease.
    Zha D; Wu X
    J Nephrol; 2023 Jan; 36(1):17-29. PubMed ID: 35704261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and its therapeutic potential in diabetic nephropathy.
    Han YP; Liu LJ; Yan JL; Chen MY; Meng XF; Zhou XR; Qian LB
    Front Endocrinol (Lausanne); 2023; 14():1139444. PubMed ID: 37020591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue.
    Guo Q; Zhong W; Duan A; Sun G; Cui W; Zhuang X; Liu L
    Pharmacol Res; 2019 Jun; 144():151-157. PubMed ID: 30935943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
    Eisenreich A; Leppert U
    Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference in the nutrient-sensing and inflammatory signaling pathways by renal autophagy activation in mice with late stage diabetic nephropathy.
    Li D; Yuan S; Deng Y
    Int Urol Nephrol; 2024 Jan; 56(1):303-311. PubMed ID: 37355515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential.
    Yang D; Livingston MJ; Liu Z; Dong G; Zhang M; Chen JK; Dong Z
    Cell Mol Life Sci; 2018 Feb; 75(4):669-688. PubMed ID: 28871310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.